Filter Results
:
(627)
Show Results For
-
All HBS Web
(627)
- People (2)
- News (54)
- Research (438)
- Events (2)
- Multimedia (5)
- Faculty Publications (389)
Show Results For
-
All HBS Web
(627)
- People (2)
- News (54)
- Research (438)
- Events (2)
- Multimedia (5)
- Faculty Publications (389)
- 01 Feb 1997
- News
Shaping the Future of Business: Entrepreneurial Evolution at HBS
a thriving organization of significant scale. Gordon M. Binder (MBA '62) played a key role in just such a transition at Amgen, which now ranks as the largest biotechnology firm in the world. A California-based firm that discovers,...
View Details
- October 2020 (Revised April 2022)
- Case
When Institutions Fail: HIV/AIDS in the 1980s
By: Tom Nicholas and Christian Godwin
During the early 1980s, young gay men in urban centers such as San Francisco and New York City began contracting a mysterious illness that would come to be known as HIV/AIDS. A diagnosis meant almost certain death, with a less than 1% survival rate. Conflicting...
View Details
Keywords:
Ethics;
Policy;
Government and Politics;
Health Pandemics;
History;
Rights;
Media;
Organizations;
Business and Community Relations;
Religion;
Social Psychology;
Identity;
Prejudice and Bias;
Social Issues;
Public Opinion;
Pharmaceutical Industry;
Biotechnology Industry;
Health Industry;
Journalism and News Industry;
Media and Broadcasting Industry;
Public Administration Industry;
United States
Nicholas, Tom, and Christian Godwin. "When Institutions Fail: HIV/AIDS in the 1980s." Harvard Business School Case 821-002, October 2020. (Revised April 2022.)
- January 2016 (Revised February 2016)
- Course Overview Note
The Sustainable Core: Operations Management
By: Michael W. Toffel and L. Beril Toktay
This note is designed to help faculty embed environmental sustainability content into their core Operations Management course at the MBA or undergraduate level. It can also be used to identify cases with environmental content that can be used in operations electives...
View Details
Keywords:
Environmental Management;
Operations Management;
Sustainable Operations;
Environmental Regulation;
Operations;
Supply Chain;
Supply Chain Management;
Agriculture and Agribusiness Industry;
Biotechnology Industry;
Food and Beverage Industry;
Construction Industry;
Forest Products Industry;
Retail Industry
Toffel, Michael W., and L. Beril Toktay. "The Sustainable Core: Operations Management." Harvard Business School Course Overview Note 616-022, January 2016. (Revised February 2016.)
- 29 Oct 2000
- Research & Ideas
The Entrepreneurial Venture: A Conversation
dormant at the time. But with the growth of the microprocessor and of biotechnology in the late 1970s, as well as the deregulation of the airline and financial services industries, new opportunities for eager entrepreneurs were created....
View Details
Keywords:
by Susan Young
- 01 Sep 2011
- News
Green Day
good ROI.” Diniz began to brainstorm with Paulo Puterman, a friend studying to get his PhD in biotechnology at the University of São Paulo who also happened to be focused on the highly efficient elephant grass/electricity equation. “After...
View Details
- September 1989 (Revised December 1989)
- Case
Beef Hormone Trade Dispute
By: Ray A. Goldberg
Keywords:
Trade;
Agribusiness;
Food;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry
Goldberg, Ray A. "Beef Hormone Trade Dispute." Harvard Business School Case 590-035, September 1989. (Revised December 1989.)
- 14 Sep 2010
- First Look
First Look: September 14, 2010
involved in the production of clean energy. One of the key bottlenecks threatening innovation in energy production is the inability of VCs to exit their investments at the appropriate time. This hurdle did exist in industries such as View Details
Keywords:
Sean Silverthorne
- 12 Oct 2006
- First Look
First Look: October 12, 2006
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707438 PublicationsScience Business: Promise, Performance and the Future of Biotech Author:Gary P. Pisano Publication:Harvard Business School Press (forthcoming) Abstract Why has the View Details
Keywords:
Sean Silverthorne
- January 2007 (Revised January 2007)
- Background Note
Note on the U.S. Food and Drug Administration
By: Robert F. Higgins, Richard G. Hamermesh and Virginia Fuller
Describes the U.S. FDA with particular emphasis on its role in the development of new drugs, biologic products, and medical devices today. Provides context for the drug approval process by describing the FDA's history and organizational structure.
View Details
Keywords:
Health;
Governance Compliance;
Policy;
Product Development;
Government and Politics;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
United States
Higgins, Robert F., Richard G. Hamermesh, and Virginia Fuller. "Note on the U.S. Food and Drug Administration." Harvard Business School Background Note 807-050, January 2007. (Revised January 2007.)
- 03 Aug 2010
- First Look
First Look: August 3
Baldwin, Bo Becker, and Vincent DessainHarvard Business School Case 210-040 Franz Humer, CEO of the Roche Group, must decide whether to mount a hostile tender offer for the publicly owned shares of Roche's biotechnology subsidiary,...
View Details
Keywords:
Martha Lagace
- Web
Dean Srikant Datar’s 2023 Commencement Remarks | About
biotechnology firm Vertex, where she led teams to make innovative medicines that treat chronic diseases like cystic fibrosis. Amid a busy career, Depelsha McGruder acted courageously to launch Moms of Black Boys United to celebrate the...
View Details
- 26 Sep 2006
- First Look
First Look: September 26, 2006
Danner was about to make his first presentation to the board of directors of Codon Devices, a one-year-old biotechnology start-up based in Cambridge, Massachusetts. After a month as the company's CEO, Danner was prepared to lay out his...
View Details
Keywords:
Sean Silverthorne
- Web
CFO Letter - Annual Report 2019
activity of MBA education at the School. Some of these initiatives add programmatic complexity or incremental costs. For example, more students at HBS are seeking to integrate the skills they are learning in the MBA program with cross-disciplinary knowledge in areas...
View Details
- 20 Nov 2006
- Research & Ideas
Open Source Science: A New Model for Innovation
coming up with a solution that could be off-the-shelf. So when they actually see solutions from this type of method, they're blown away. Recently, an internal science team at a U.S.-based major biotechnology firm was assigned to develop a...
View Details
Keywords:
by Martha Lagace
- 23 Jan 2019
- News
The Promise of Personalized Medicine
as a biotechnology company, Myofinity Biosciences. Those two organizations have taken two different paths. They’re not connected. The 501(c)(3), Terry’s Foundation (now Cure Rare Disease), is doing something incredibly unprecedented. What...
View Details
- May 20, 2016
- Comment
World Health Organization Lacks Leadership to Combat Pandemics
By: John A. Quelch
When it comes to emergency preparedness for pandemics, the World Health Organization is falling short. It has not provided prompt and clear leadership to the world in combating either the Ebola or Zika viruses. Its leadership has been low energy, its representatives...
View Details
Keywords:
Global Health;
World Health Organization;
World Bank;
Pandemics;
Emergency Preparedness;
Experience and Expertise;
Decisions;
Forecasting and Prediction;
Communication Strategy;
Nonverbal Communication;
Framework;
Governance;
Government and Politics;
Health;
Management;
Practice;
Problems and Challenges;
Projects;
Risk and Uncertainty;
Human Needs;
Civil Society or Community;
Social Issues;
Welfare or Wellbeing;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Africa;
Asia;
Europe;
Latin America;
North and Central America;
South America;
West Indies
Quelch, John A. "World Health Organization Lacks Leadership to Combat Pandemics." Harvard Business School Working Knowledge (May 20, 2016).
- January 2017 (Revised March 2017)
- Case
Royal DSM: From Continuous Transformation to Organic Growth
By: William W. George, Carin-Isabel Knoop and Amram Migdal
Royal DSM CEO Feike Sijbesma was pondering the challenges of shifting DSM’s global organization from the constant transformations of the past 100 years to creating organic growth. When Sijbesma took the helm as CEO in 2007, he further pushed and completed the company’s...
View Details
Keywords:
Organic Growth;
Organizational Change;
M&A;
Mergers And Acquisitions;
Divestment;
Business Ventures;
Business Divisions;
Business Growth and Maturation;
Restructuring;
Change;
Change Management;
Transformation;
Transition;
Engineering;
Chemicals;
Mining;
Ethics;
Values and Beliefs;
Finance;
Capital Markets;
Financial Markets;
Food;
Globalization;
Global Strategy;
Globalized Firms and Management;
Globalized Markets and Industries;
Health;
Nutrition;
History;
Leadership;
Leadership Development;
Leadership Style;
Leading Change;
Management;
Business or Company Management;
Growth and Development Strategy;
Growth Management;
Management Practices and Processes;
Management Style;
Organizations;
Corporate Social Responsibility and Impact;
Mission and Purpose;
Organizational Change and Adaptation;
Organizational Culture;
Organizational Design;
Ownership;
Public Ownership;
Performance;
Strategy;
Adaptation;
Consolidation;
Corporate Strategy;
Value;
Value Creation;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Europe;
Netherlands
George, William W., Carin-Isabel Knoop, and Amram Migdal. "Royal DSM: From Continuous Transformation to Organic Growth." Harvard Business School Case 317-063, January 2017. (Revised March 2017.)
- 23 Jun 2003
- Research & Ideas
Historically Speaking: A Roundtable at HBS
Pharmaceutical Industries, to be published by The Free Press in 2004]. It includes a chapter on biotechnology, the next industry that will create a sea change in our lives. Spar: And biotechnology will go through the same pattern of...
View Details
Keywords:
by Jim Aisner
- Web
FY19 Baker Library Annual Report
and SEAS doctoral students and Kirkland House undergrads. Archival Donations Henri A. Termeer Papers, ca. 1980-2011Henri A. Termeer served for almost thirty years as Chairman, President and CEO of Genzyme Corporation, a pioneering enterprise in the growth of the View Details
- 01 Dec 2020
- News
In Review
Under his ten-and-one-half years of leadership, the School launched FIELD and HBS Online. It created two joint degree programs: an MS/MBA in Engineering in conjunction with the Paulson School of Engineering and Applied Sciences, and an MS/MBA in Life Sciences & View Details